The global influenza diagnostics market attained a value of USD 657 million in 2019. The influenza diagnostics market is further expected to grow in the forecast period of 2020-2025 at a CAGR of 9% to reach USD 1103.3 million by 2025. The influenza diagnostics market is being driven by the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of influenza.
Get a Free Sample Report with Table of Content - Download Now
Properties and Applications
Influenza diagnostics help determine if a person is suffering from influenza by detecting the influenza viral nucleoprotein antigen. These are commercially available and help provide results in as less as 30 minutes span, exhibiting colour change or other visual signals.
The global influenza diagnostics market is segmented into types and end-uses.
The industry can be broadly categorised based on its types as:
The traditional diagnostic test is further divided into rapid influenza diagnostic test (RIDT), viral culture, direct fluorescent antibody (DFA) test, and serological assay. The molecular diagnostic assay is subdivided into reverse transcription polymerase chain reaction (RT-PCR), nucleic acid sequence-based amplification (NASBA) test, loop-mediated isothermal amplification-based assay (LAMP), simple amplification-based assay (SAMBA), and other molecular diagnostic assays.
The industry can be divided based on its end-use into:
The EMR report looks into the regional influenza diagnostics markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The influenza diagnostics market is being driven by the rising prevalence of influenza over the forecast period. The growing awareness among the population about the early diagnosis and effective treatment of influenza is aiding the market growth. It is also recommended for all patients with suspected influenza, thus, further enhancing the influenza diagnostics industry. The influenza diagnostics market is positively influenced by the rising funding for influenza diagnosis, research, and treatment. The disease can further degrade the health and develop complications in an individual, like pneumonia, bronchitis, asthma flare-ups, heart problems, and an ear infection, among others, creating an immediate need for influenza diagnostic and treatments, further propelling the influenza diagnostics market forward.
The report presents a detailed analysis of the following key players in the global influenza diagnostics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the influenza diagnostics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Questions Answered in the Market Report:
1.1 Objectives of the Study
1.2 Key findings of the Study
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Inference Data
3 Executive Summary
3.1 Market Overview
3.2 Market Analysis
4 Global Influenza Diagnostics Market Analysis
4.1 Global Influenza Diagnostics Historical Market (2015-2019) & Forecast (2020-2025)
4.2 Global Influenza Diagnostics Market Breakup by Type
4.2.1 Traditional Diagnostic Test
126.96.36.199 Rapid Influenza Diagnostic Test (RIDT)
188.8.131.52 Viral Culture
184.108.40.206 Direct Fluorescent Antibody (DFA) Test
220.127.116.11 Serological Assay
4.2.2 Molecular Diagnostic Assay
18.104.22.168 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
22.214.171.124 Nucleic Acid Sequence-Based Amplification (NASBA) Test
126.96.36.199 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
188.8.131.52 Simple Amplification-Based Assay (SAMBA)
184.108.40.206 Other Molecular Diagnostic Assays
4.3 Global Influenza Diagnostics Market Breakup by Type: Historical Market (2015-2019) & Forecast (2020-2025)
4.3.1 Traditional Diagnostic Test
220.127.116.11 Rapid Influenza Diagnostic Test (RIDT)
18.104.22.168 Viral Culture
22.214.171.124 Direct Fluorescent Antibody (DFA) Test
126.96.36.199 Serological Assay
4.3.2 Molecular Diagnostic Assay
188.8.131.52 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
184.108.40.206 Nucleic Acid Sequence-Based Amplification (NASBA) Test
220.127.116.11 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
18.104.22.168 Simple Amplification-Based Assay (SAMBA)
22.214.171.124 Other Molecular Diagnostic Assays
4.4 Global Influenza Diagnostics Market Breakup by End Use
4.4.2 Research Laboratory
4.5 Global Influenza Diagnostics Market Breakup by End Use: Historical Market (2015-2019) & Forecast (2020-2025)
4.5.2 Research Laboratory
4.6 Global Influenza Diagnostics Market Breakup by Region
4.6.1 North America
126.96.36.199 United States of America
188.8.131.52 United Kingdom
4.6.3 Asia Pacific
4.6.4 Latin America
4.6.5 Middle East & Africa
184.108.40.206 Saudi Arabia
220.127.116.11 United Arab Emirates
18.104.22.168 South Africa
4.7 Global Influenza Diagnostics Market Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
4.7.1 North America
22.214.171.124 United States of America
126.96.36.199 United Kingdom
4.7.3 Asia Pacific
4.7.4 Latin America
4.7.5 Middle East & Africa
188.8.131.52 Saudi Arabia
184.108.40.206 United Arab Emirates
220.127.116.11 South Africa
5 SWOT Analysis
6 Porter’s Five Forces Analysis
6.2 Buyer’s Power
6.3 Supplier’s Power
6.4 New Entrants
6.5 Degree of Rivalry
7 EMR’s Key Indicators for Demand
8 EMR’s Key Indicators for Price
9 Key Players & Company Profiles
9.1 Abbott [ABT (NYSE)]
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 Becton, Dickinson and Company [BDX (NYSE)]
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Coris BioConcept
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 DiaSorin SpA
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 F. Hoffmann-La Roche Ltd. [ROG (SWX)]
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 Luminex Corporation [LMNX (NASDAQ)]
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Meridian Bioscience Inc. [VIVO (NASDAQ)]
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 Quidel Corporation [QDEL (NASDAQ)]
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Sekisui Diagnostics
9.9.1 Company Overview
9.9.2 Financial Analysis
9.10 Thermo Fisher Scientific Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
10 Events and Developments
EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
The global veterinary infectious disease diagnostics market stood at a value of nearly USD 1.5 billion in 2019. The industry is further expected to grow at a CAGR of almost 8.8% in the forecast period...
Vitamin D deficiency has now become a common problem affecting many people worldwide, especially older adults. As vitamin D plays a key role in bone development as well as calcification, many people a...
The global shoulder replacement market is projected to attain a value of USD 3 billion by the end of 2025, growing in the forecast period of 2020-2025 at a CAGR of 7.5%. The shoulder replacement marke...
The market is significantly being supported by the integration of digital health technology in bacterial disease rapid diagnostics. North America is among the most significant regions for the market. ...
The global idiopathic pulmonary fibrosis treatment market stood at USD 2.2 billion in 2019. The idiopathic pulmonary fibrosis treatment market is expected to grow at a CAGR of about 12% in the forecas...
Buy Full Version
"Influenza Diagnostics Market" Purchase Enquiry